Holen Sie sich die Stockscreener-App
69.36
5.22%
-3.82
Handel nachbörslich:
69.00
-0.36
-0.52%
Schlusskurs vom Vortag:
$73.18
Offen:
$73.09
24-Stunden-Volumen:
997.14K
Relative Volume:
1.15
Marktkapitalisierung:
$2.01B
Einnahmen:
$915.25M
Nettoeinkommen (Verlust:
$131.14M
KGV:
15.51
EPS:
4.472
Netto-Cashflow:
$96.71M
1W Leistung:
+0.43%
1M Leistung:
+10.11%
6M Leistung:
+34.47%
1J Leistung:
-6.52%
1-Tages-Spanne:
$68.50
$73.25
1-Wochen-Bereich:
$68.13
$73.25
52-Wochen-Spanne:
$38.91
$147.03
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
69.36 | 2.04B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Top Inspire Medical Systems (INSP) Competitors 2026 - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Price, News, Quote & History - Yahoo! Finance Canada
100th patient in the UK receives Inspire therapy implant - Manchester University NHS Foundation Trust
Inspire Medical Systems Inc (INSP) Shares Fall 3.1% -- What GF S - GuruFocus
Inspire Medical Systems, Inc. (INSP) Latest Stock News & HeadlinesYahoo Finance - ca.finance.yahoo.com
Inspire Medical Systems, Inc. (INSP) latest stock news and headlines - Yahoo Finance UK
Inspire Medical Systems, Inc. (INSP) latest stock news and headlines – Yahoo Finance - Yahoo Finance Singapore
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo Finance
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Zacks Investment Research
Inspire Medical Systems, Inc. (INSP) stock price, news, quote and historyYahoo Finance - sg.finance.yahoo.com
Inspire Medical Systems Drops 5.2% After Freedom Capital Markets Maintains Buy - AlphaStreet
ETFs Investing in Inspire Medical Systems, Inc. Stocks - TradingView
(INSP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday - benzinga.com
Freedom Capital Markets maintains Buy rating on Inspire Medical Systems, $97 price target - TradingView
Freedom Capital Markets Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $97 - Moomoo
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Challenges of Growth in the Medical Devices Sector - DirectorsTalk Interviews
Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 5 - GuruFocus
Inspire Medical Systems (INSP) And The Valuation Debate Following Its Inspire V Delay - simplywall.st
Inspire Medical Systems, Inc. Common Stock (NYSE:INSP) Price Chart - The Chronicle-Journal
Inspire Medical Systems (INSP) Stock Could Be 14% Undervalued On Cash Flow - Yahoo Finance
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network - TradingView
Inspire Medical Systems INSP Jumps After Stifel Price Target Hike - StocksToTrade
InvestingPro’s Fair Value spotted 65% gain in Inspire Medical stock By Investing.com - Investing.com Australia
Why Inspire Medical Systems (INSP) Stock Is Up Today - Yahoo Finance
Inspire Medical Systems Inc (INSP) Stock Up 7.2% and Still Under - GuruFocus
Inspire Medical Systems Inc (INSP) Stock Up 7.2% and Still Undervalued -- GF Score: 58/100 - GuruFocus
INSP Maintains by Stifel -- Price Target Raised to $80.00 - GuruFocus
Inspire Medical Systems Jumps 8.7% Amid Sector-Wide Rally - AlphaStreet
Price-Driven Insight from (INSP) for Rule-Based Strategy - news.stocktradersdaily.com
Stifel raises Inspire Medical stock price target on reimbursement outlook By Investing.com - Investing.com India
Inspire Medical at Wells Fargo conference: growth reset takes shape By Investing.com - Investing.com South Africa
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
Inspire Medical at Wells Fargo conference: growth reset takes shape - Investing.com
INSP: Coding clarity, Inspire V outcomes, and Project Horizon set stage for renewed growth - TradingView
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Potential with a 17.97% Return on Equity - DirectorsTalk Interviews
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Inspire Medical (INSP) awards 6,350 RSUs vesting over 3 years - Stock Titan
Inspire Medical Systems | 4: Statement of changes in beneficial ownership of securities - Moomoo
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):